According to the latest research report by IMARC Group, The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032. More Info:- https://www.imarcgroup.com/copd-asthma-devices-market
Asthma & COPD Drugs Market size is estimated to reach $42.1 billion by 2027, growing at a CAGR of 4.7% during the forecast period 2022-2027. Asthma & COPD Drugs have the principal goal to reverse bronchoconstriction which is hindering the airway to enhance air flow in and out of the lungs. Bronchodilators are principal in the treatment of airways ailments. They are the backbone of the present handling of chronic obstructive pulmonary disease (COPD) and are crucial in the symptomatic handling of asthma, though controversies around the application of these medications prevail.
TMR’s US & China Asthma and COPD Drugs Market market report helps analyze trends and significant developments in the industry. In addition, it also provides insights predicting growth rates of the US & China Asthma and COPD Drugs Market market using detailed assessment of key drivers, threats, restraints, along with opportunities that are likely to open doors for growth in coming years. For More Technical Insights, Download Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15857
Asthma & COPD market status and forecast, categorizes the global Asthma & COPD market size (value & volume) by manufacturers, type, application, and region.
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. Full report: https://kbvresearch.com/global-copd-and-asthma-devices-market/
The global COPD & Asthma Devices market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
These chronic respiratory diseases are caused by numerous environmental factors or are genetically acquired requires constant care management. As per WHO in 2015, approximately 3 million deaths were caused due to COPD, being the progressive and life-threatening disease of lungs, this accounts for around 5% of the total global deaths per year.
The Smart Inhalers in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide.
The Business Research Company’s Anti-Asthmatics And COPD Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/2m00bAa
Global smart inhalers market size is expected to reach $2.36 Bn by 2028 at a rate of 9.8%, segmented as by type, dry powdered inhalers (dpis), metered dose inhalers (mdis)
COPD Drug Market Opportunity & Clinical Pipeline Analysis @ http://www.reportsnreports.com/reports/280894-copd-drug-market-opportunity-clinical-pipeline-analysis.html “COPD Drug Market Opportunity & Clinical Pipeline Analysis” Report Highlight: • COPD Drug Market Overview • COPD Patient Base: Global, US & Europe • FDA & EMA Guidelines on Clinical Investigation of COPD Drugs • COPD Drug Clinical Pipeline by Phase & Country • COPD Drug in Development Phase: 174 • Majority of COPD Drugs in Preclinical Phase: 72 • Marketed COPD Drugs: 36 • Discontinued & Suspended COPD Drug Profiles
The global anti-asthmatics and copd drugs market was valued at about $33.4 billion in 2018 and is expected to grow to $42.01 billion at a CAGR of 5.9% through 2022. Read more at http://bit.ly/2MO6KQM
Global Anti-Asthmatics And COPD Drugs Market by The Business Research Company is segmented as Bronchodilators , Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs
Global Anti-Asthmatics And COPD Drugs Market by The Business Research Company is segmented as Bronchodilators , Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs https://bit.ly/3riKJ1o
The global anti-asthmatics and COPD drugs market size is expected to grow from $80.73 billion in 2021 to $88.18 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%.
The major players covered in the global anti-asthmatics and copd drugs market are Novartis AG, Merck & Co, GlaxoSmithKline , Boehringer Ingelheim Gmbh,
global anti-asthmatic and COPD drugs market by the business research company is segmented as bronchodilators, monoclonal antibodies, anti-inflammatory drugs, combination drugs https://bit.ly/3CQRECw
The Oxygen Therapy Devices Market is expanding rapidly, due to several major factors. First and foremost, the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea is a significant driver, owing to factors such as air pollution, smoking, and an aging population. The need for oxygen therapy devices and services has increased as these illnesses grow more common.
Anti-Asthmatics And COPD Drugs Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. See Full Report @ http://bit.ly/1zVmJyK
“Tracheostomy Products Market” Report will provide important aspects with overall outlook of the market worldwide, According to Adroit Market Research.
In the recent past, the global nebuliser market has been on a steady upward trajectory. These nebulisers are widely used to treat cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). For More Information of Nebuliser Market Visit: https://www.fairfieldmarketresearch.com/report/nebuliser-market
Digital Dose Inhalers Market is driven by rising demand for digital dose inhalers, due to the increasing geriatric population, rising prevalence of respiratory diseases such as asthma and COPD across the globe.
Respiratory Disease Testing/Diagnostics Market size in 2019 is estimated to be $5.9 billion, growing at a CAGR of 5% during the forecast period 2020-2025. Respiratory disease is the disease that affects the lungs and respiratory system. It is caused by infection, smoking tobacco, or air pollution. Asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are some of the major respiratory diseases. The growing geriatric population with respiratory disorders and technological advancement in respiratory diagnostic testing are the major factors driving the growth of the market.
Mechanical ventilator, sometimes also known as ventilator, breathing machine or respirator, is a device which is used by healthcare institutions and hospitals in the management of patient’s breathing problems. Usage of mechanical ventilation process is the last choice for a patient who is suffering from breathing problems and cannot maintain adequate oxygenation to maintain life. Mechanical ventilation process is mainly used in the treatment of chronic obstructive pulmonary disease (COPD), apnea, acute lung injury and hypoxemia. Globally, increasing incidences of chronic diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other lunch disorders are expected to remain key growth drivers for the mechanical ventilation & accessories market during the period of study.
The airway management devices market is projected to reach USD 2.5 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 5.8% during the forecast period. Airway management devices market is majorly driven by the increasing prevalence of chronic respiratory diseases such as COPD and asthma and surge in the number of patients requiring intensive and emergency care. Moreover, presence of favorable reimbursement coverage across developed countries, and the high incidence of pre-term births, increasing public and private investments for the development of healthcare infrastructure, and rising geriatric population is supporting the market growth.
Adrenergic drugs, also named as sympathomimetic drugs stimulate a response from the adrenergic receptors. This drug is used to stimulate the sympathetic nervous system located in the chest and lower back region of the spinal cord. These drugs stimulate the chemical messenger epinephrine and norepinephrine from the adrenal gland, or replicate the action of these chemical messengers. There are five main categories of adrenergic receptors as α₁, α₂, β₁, β₂, and β₃. Adrenergic drugs are used to increase the breathing rate, heartbeat, sweating, urine flow, and prevent bleeding. There are three major types of adrenergic drugs most commonly used such as Bronchodilators, vasopressors, and cardiac stimulators. This drug is used in the treatment of various life-threatening conditions including chronic obstructive pulmonary diseases (COPD), asthma, cardiac arrest, shock, and allergic reactions.
The growth of the smart inhalers market is attributed to the increasing prevalence of asthma and COPD across the globe. According to the latest research by the company, the global smart inhalers market is expected to account for revenue over US$ 130 Mn in terms of value by the end of 2026. The smart inhalers market is expected to witness rapid growth with a CAGR pegged at 12.2% through 2026. The smart inhalers market is moderately consolidated due to the presence of leading international players.
Rise in incidences of respiratory disorders such as chronic obstructive pulmonary disorder (COPD), asthma, pneumonia, and other severe respiratory infections acts as a key driving factor for growth of the global cough remedies market. Furthermore, increase in product launches post FDA approval would help the industry gain maximum revenue. Surge in clinical trials for R&D of cough remedies is further projected to help the industry grow during the forecast period.
Respiratory Disease Testing Market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period.
Bharat Book Bureau Provides the Trending Market Research Report; on “Global Oxygen Therapy Equipment Market Forecast 2017- 2022”, (https://www.bharatbook.com/healthcare-market-research-reports-948838/global-oxygen-therapy-concentrators-copd-asthma-cystic-fibrosis-respiratory-distress.html)The report has coated and analysed the potential of worldwide chemical element medical care instrumentality Market and provides statistics and knowledge on market size, shares and growth factors.
Respiratory Disease Testing Market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period.
The world mechanical ventilators market is estimated to garner $3.9 billion by 2022, with a CAGR of 5.4% from 2016 to 2022. The increasing incidence of chronic diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other lunch disorders, and increasing number of accidental emergencies lead to the substantial requirement of mechanical ventilators. In addition, growing geriatric population prone to respiratory emergencies is one of the key drivers of the market. Read more details @ https://www.alliedmarketresearch.com/mechanical-ventilators-market
Big Market Research adds a report “Global Respiratory Disease Testing Market- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2019" Get Complete Report @ http://www.bigmarketresearch.com/global-respiratory-disease-testing-2015-2019-market Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/355988
The global respiratory care devices market was valued at USD 21.00 billion in 2018. Rising prevalence of COPD, asthma and other respiratory disorders on account of increasing pollution across various countries is likely to fuel the market growth in coming years.
The global pulmonary devicesmarket,based on type, is segmented into therapeutic devices, consumables and accessories, diagnostic devices, and monitoring devices.The therapeutic devicessegment held the largest share of the market in 2019, and this growth is ascribed tothe increasing demand of inhalers and nebulizers by patients suffering with asthma and chronic obstructive pulmonary disorders.
Dry Powder Inhaler Market By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Cardiovascular Disease, Diabetes , Others) By Type (Single dose, Multi-dose) By End-User (Hospitals & Clinics, Homecare) and Region - Global Forecast 2016 to 2024
Rise in prevalence of various respiratory disorders is a key factor driving nebulizers market revenue growth Market Size – USD 1.12 Billion in 2021, Market Growth – at a CAGR of 7.6%, Market Trends – Growing environmental and air pollution
Increase in prevalence of target diseases including diabetes, asthma, chronic obstructive pulmonary disorder (COPD), and cardiovascular diseases coupled with rapid technological advancements in drug delivery devices are key factors driving the global electronic drug delivery systems market.
Global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019. COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals with breathing problems.